Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 3
2002 6
2003 2
2004 5
2005 1
2006 3
2007 7
2008 6
2009 8
2010 9
2011 9
2012 6
2013 1
2014 1
2015 4
2016 6
2017 9
2018 2
2019 4
2020 12
2021 14
2022 14
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, Aktas O, Baum K, Berghoff M, Bittner S, Chan A, Czaplinski A, Deisenhammer F, Di Pauli F, Du Pasquier R, Enzinger C, Fertl E, Gass A, Gehring K, Gobbi C, Goebels N, Guger M, Haghikia A, Hartung HP, Heidenreich F, Hoffmann O, Kallmann B, Kleinschnitz C, Klotz L, Leussink VI, Leutmezer F, Limmroth V, Lünemann JD, Lutterotti A, Meuth SG, Meyding-Lamadé U, Platten M, Rieckmann P, Schmidt S, Tumani H, Weber F, Weber MS, Zettl UK, Ziemssen T, Zipp F; ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG). Wiendl H, et al. Among authors: lunemann jd. Ther Adv Neurol Disord. 2021 Aug 18;14:17562864211039648. doi: 10.1177/17562864211039648. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34422112 Free PMC article. Review.
Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis.
Schneider-Hohendorf T, Gerdes LA, Pignolet B, Gittelman R, Ostkamp P, Rubelt F, Raposo C, Tackenberg B, Riepenhausen M, Janoschka C, Wünsch C, Bucciarelli F, Flierl-Hecht A, Beltrán E, Kümpfel T, Anslinger K, Gross CC, Chapman H, Kaplan I, Brassat D, Wekerle H, Kerschensteiner M, Klotz L, Lünemann JD, Hohlfeld R, Liblau R, Wiendl H, Schwab N. Schneider-Hohendorf T, et al. Among authors: lunemann jd. J Exp Med. 2022 Nov 7;219(11):e20220650. doi: 10.1084/jem.20220650. Epub 2022 Sep 1. J Exp Med. 2022. PMID: 36048016 Free PMC article.
Autophagy pathways in autoimmune diseases.
Keller CW, Adamopoulos IE, Lünemann JD. Keller CW, et al. Among authors: lunemann jd. J Autoimmun. 2023 Apr;136:103030. doi: 10.1016/j.jaut.2023.103030. Epub 2023 Mar 29. J Autoimmun. 2023. PMID: 37001435 Free PMC article. Review.
Synthetic Cell-Based Immunotherapies for Neurologic Diseases.
von Baumgarten L, Stauss HJ, Lünemann JD. von Baumgarten L, et al. Among authors: lunemann jd. Neurol Neuroimmunol Neuroinflamm. 2023 Jun 29;10(5):e200139. doi: 10.1212/NXI.0000000000200139. Print 2023 Sep. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37385738 Free PMC article. Review.
International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis.
Chen X, Tsvetkov AS, Shen HM, Isidoro C, Ktistakis NT, Linkermann A, Koopman WJH, Simon HU, Galluzzi L, Luo S, Xu D, Gu W, Peulen O, Cai Q, Rubinsztein DC, Chi JT, Zhang DD, Li C, Toyokuni S, Liu J, Roh JL, Dai E, Juhasz G, Liu W, Zhang J, Yang M, Liu J, Zhu LQ, Zou W, Piacentini M, Ding WX, Yue Z, Xie Y, Petersen M, Gewirtz DA, Mandell MA, Chu CT, Sinha D, Eftekharpour E, Zhivotovsky B, Besteiro S, Gabrilovich DI, Kim DH, Kagan VE, Bayir H, Chen GC, Ayton S, Lünemann JD, Komatsu M, Krautwald S, Loos B, Baehrecke EH, Wang J, Lane JD, Sadoshima J, Yang WS, Gao M, Münz C, Thumm M, Kampmann M, Yu D, Lipinski MM, Jones JW, Jiang X, Zeh HJ, Kang R, Klionsky DJ, Kroemer G, Tang D. Chen X, et al. Among authors: lunemann jd. Autophagy. 2024 Mar 24:1-34. doi: 10.1080/15548627.2024.2319901. Online ahead of print. Autophagy. 2024. PMID: 38442890 Free article. Review.
Next-generation antibody-based therapies in neurology.
Ruck T, Nimmerjahn F, Wiendl H, Lünemann JD. Ruck T, et al. Among authors: lunemann jd. Brain. 2022 May 24;145(4):1229-1241. doi: 10.1093/brain/awab465. Brain. 2022. PMID: 34928330 Free PMC article. Review.
Neonatal Fc Receptor-Targeted Therapies in Neurology.
Nelke C, Spatola M, Schroeter CB, Wiendl H, Lünemann JD. Nelke C, et al. Among authors: lunemann jd. Neurotherapeutics. 2022 Apr;19(3):729-740. doi: 10.1007/s13311-021-01175-7. Epub 2022 Jan 7. Neurotherapeutics. 2022. PMID: 34997443 Free PMC article. Review.
Targeting Inflammasomes to Treat Neurological Diseases.
Lünemann JD, Malhotra S, Shinohara ML, Montalban X, Comabella M. Lünemann JD, et al. Ann Neurol. 2021 Aug;90(2):177-188. doi: 10.1002/ana.26158. Epub 2021 Jul 17. Ann Neurol. 2021. PMID: 34219266 Review.
Antibody-mediated cell depletion therapies in multiple sclerosis.
Mariottini A, Muraro PA, Lünemann JD. Mariottini A, et al. Among authors: lunemann jd. Front Immunol. 2022 Sep 12;13:953649. doi: 10.3389/fimmu.2022.953649. eCollection 2022. Front Immunol. 2022. PMID: 36172350 Free PMC article. Review.
133 results